Al-Midfai Younus, Bengio Moshe, Aneja Pallavi
Internal Medicine, HCA Healthcare Westside Hospital, Plantation, USA.
Internal Medicine, Northwest Medical Center, Margate, USA.
Cureus. 2024 Nov 3;16(11):e72940. doi: 10.7759/cureus.72940. eCollection 2024 Nov.
In the early era of COVID-19, characterization of long-term complications was unfeasible. But in early 2021, the authors came across a patient with a new diagnosis of Acute Myeloid Leukemia (AML) that was highly suspected as being secondary to a previous COVID-19 infection. The similarities of this anomaly to Hodgkin Lymphoma occurring after Epstein Barr Virus prompted the authors to perform a qualitative review of the literature for a possible pathway of how COVID-19 can cause AML.
在新冠疫情早期，对长期并发症进行特征描述是不可行的。但在2021年初，作者遇到一名新诊断为急性髓系白血病（AML）的患者，高度怀疑该病继发于先前的新冠病毒感染。这种异常情况与爱泼斯坦-巴尔病毒感染后发生的霍奇金淋巴瘤的相似性，促使作者对文献进行定性综述，以探寻新冠病毒导致急性髓系白血病的可能途径。
